Company Filing History:
Years Active: 2025
Title: Akiko Noma: Innovator in Genetic Therapeutics
Introduction
Akiko Noma is a prominent inventor based in Boston, MA, known for her groundbreaking work in genetic therapeutics. She has made significant contributions to the field of molecular biology, particularly in the development of innovative solutions for genetic disorders.
Latest Patents
Noma holds a patent for ABCA4 trans-splicing molecules. This patent describes nucleic acid trans-splicing molecules, including pre-mRNA trans-splicing molecules and RNA exon editing molecules, which are capable of correcting mutations in the ABCA4 gene. These molecules are particularly useful in treating disorders such as ABCA4-associated retinal dystrophies, including Stargardt Disease and cone-rod dystrophy. The patent also outlines methods for using these nucleic acid trans-splicing molecules to correct mutations in ABCA4, thereby providing therapeutic options for disorders linked to these mutations.
Career Highlights
Akiko Noma is currently associated with Ascidian Therapeutics, Inc., where she continues to advance her research in genetic therapies. Her work has garnered attention for its potential to transform treatment approaches for genetic disorders.
Collaborations
Noma collaborates with notable colleagues, including Rebekka Krumbach and Scott J. Dooley, who contribute to her research endeavors and the development of innovative therapeutic solutions.
Conclusion
Akiko Noma's contributions to genetic therapeutics exemplify the impact of innovative research on the treatment of genetic disorders. Her work continues to inspire advancements in the field and offers hope for patients affected by these conditions.